LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹2,636 Cr | ₹2,390 Cr | ₹820 Cr | ₹992 Cr | ₹1,153 Cr |
What is the latest Total Non-Current Liabilities ratio of LUPIN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹2,636 Cr |
| Mar2025 | ₹2,390 Cr |
| Mar2024 | ₹820 Cr |
| Mar2023 | ₹992 Cr |
| Mar2022 | ₹1,153 Cr |
How is Total Non-Current Liabilities of LUPIN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,636 Cr | 10.27 | |
| Mar2025 | ₹2,390 Cr | 191.57 | |
| Mar2024 | ₹820 Cr | -17.38 | |
| Mar2023 | ₹992 Cr | -13.96 | |
| Mar2022 | ₹1,153 Cr | - | |
Compare Total Non-Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹107,899.2 Cr | -0.7% | -5.7% | 24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -0.7% |
-5.7% |
24% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses